Новости
Вышел новый номер журнала Personalized Psychiatry and Neurology
2026 Vol. 6, Issue 3
Letter
Seredenin S.B. Individualization of pharmacotherapy. Personalized Psychiatry and Neurology 2026, 6 (3): 1.
Review
Ayupova A.I., Tsaregorodtsev T.S., Solovyeva V.V., Rizvanov A.A. Biotechnological and cellular therapies in the treatment of neurodegenerative leukodystrophies. Personalized Psychiatry and Neurology 2026, 6 (3): 2-14. https://doi.org/10.52667/2712-9179-2026-6-3-2-14
Shnayder N.A., Glushchenko E.I., Abramenko A.A., Shirukova A.M., Boyko I.R., Nasyrova R.F. Association of genotypes and haplotypes of low-functioning and non-functional single nucleotide variants of the ABCB1 gene with the risk of antipsychotic-induced cognitive disorders in patients with schizophrenia spectrum disorders. Personalized Psychiatry and Neurology 2026, 6 (3): 15-27. https://doi.org/10.52667/2712-9179-2026-6-3-15-27
Shnayder N.A., Abramenko A.A., Kaisinova E.K., Glushchenko E.I., Shirukova A.M., Boiko I.R., Neznanov N.G., Nasyrova R.F. Convergence of pharmacoeconomics and pharmacogenomics of antipsychotics: A review of pharmacogenetic diagnostic tests. Personalized Psychiatry and Neurology 2026; 6 (2): 29 – 45. https://doi.org/10.52667/2712-9179-2026-6-2-29-45
Article
Evsyukov A.A., Shnayder N.A., Petrova M.M., Malinovskaya N.A., Dmitrenko D.V., Vasilyeva A.A., Petrov A.V., Fadeeva D.V., Artemeva A.S., Timechko E.E., Paramonova A.I. Epigenetic biomarkers of cardiogenic cognitive disorder in a rat model of myocardial infarction (Part 1). Personalized Psychiatry and Neurology 2026, 6 (3): 28-54. https://doi.org/10.52667/2712-9179-2026-6-3-28-54
Guseynov E., Shnayder N.A., Nasyrova R.F. Additive effects of antipsychotic duotherapy on platelet hemostasis and systemic inflammation in patients with schizophrenia spectrum disorders: A pilot cross-sectional study of hematological and serum markers. Personalized Psychiatry and Neurology 2026, 6 (3): 55-74. https://doi.org/10.52667/2712-9179-2026-6-3-55-74
Case Report
Kozlovsky V.L., Semenova N.V., Popov M.Yu., Kosterin D.N., Lepik O.V., Goncharenko A.Yu., Lyashkovskaya S.V. Intravenous valproic acid for treatment-resistant psychomotor agitation: a case series. Personalized Psychiatry and Neurology 2026, 6 (3): 75-81. https://doi.org/10.52667/2712-9179-2026-6-3-75-81
Тэги:
антидепрессанты (57) Санкт-Петербург (31) журнал (88) патогенез (9) моноамины (4) метаболизм (2) фармакодинамика (6) нейронные сети (3)